EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation

Volker Winstel iD, Evan R Abt, Thuc M Le, Caius G Radu

eLife · 21.03.2024 · 12

DOI: 10.7554/elife.91157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 21.03.2024. Verfasst von Volker Winstel und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Group Pathogenesis of Bacterial Infections; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the H…. Hauptthemen laut MEDLINE: Staphylococcal Infections, Anti-Infective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Host-directed therapy (HDT) is an emerging approach to overcome antimicrobial resistance in pathogenic microorganisms. Specifically, HDT targets host-encoded factors required for pathogen replication and survival without interfering with microbial growth or metabolism, thereby eliminating the risk of resistance development. By applying HDT and a drug repurposing approach, we demonstrate that ( R )-DI-87, a clinical-stage anticancer drug and potent inhibitor of mammalian deoxycytidine kinase (dCK), mitigates Staphylococcus aureus abscess formation in organ tissues upon invasive bloodstream infection. Mechanistically, ( R )-DI-87 shields phagocytes from staphylococcal death-effector deoxyribonucleosides that target dCK and the mammalian purine salvage pathway-apoptosis axis. In this manner, ( R )-DI-87-mediated protection of immune cells amplifies macrophage infiltration into deep-seated abscesses, a phenomenon coupled with enhanced pathogen control, ameliorated immunopathology, and reduced disease severity. Thus, pharmaceutical blockade of dCK represents an advanced anti-infective intervention strategy against which staphylococci cannot develop resistance and may help to fight fatal infectious diseases in hospitalized patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcal InfectionsAnti-Infective AgentsAnimalsHumansStaphylococcus aureusDeoxycytidine KinaseAbscessMammals

Stichwörter der Autor:innen

Staphylococcus aureusapoptosisinfectious diseasemacrophagesmicrobiology

Substanzen

Deoxycytidine KinaseAnti-Infective Agents

Autor:innen und Institutionen

  • Research Group Pathogenesis of Bacterial Infections; TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Hannover Medical School and the Helmholtz Centre for Infection Research…
  • Institute of Medical Microbiology and Hospital Epidemiology, Hannover Medical School, Hannover, Germany.
  • Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, United States.

ORCID-Profile: Volker Winstel

Förderung

  • NCI NIH HHS
  • NIH HHS
  • Deutsche Forschungsgemeinschaft
  • University of California, Los Angeles
  • National Institutes of Health

Zitieren

APA

Winstel, V., Abt, E. R., Le, T. M., & Radu, C. G. (2024). Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation. eLife, 12. https://doi.org/10.7554/elife.91157

Vancouver

Winstel V, Abt ER, Le TM, Radu CG. Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation. eLife. 2024;12. doi:10.7554/elife.91157

BibTeX
@article{Winstel2024,
  author = {Winstel, Volker and Abt, Evan R and Le, Thuc M and Radu, Caius G},
  title = {Targeting host deoxycytidine kinase mitigates Staphylococcus aureus abscess formation},
  journal = {eLife},
  year = {2024},
  volume = {12},
  doi = {10.7554/elife.91157}
}
Kostenlos starten →